AbilityPharma Competitors and Similar CompaniesClear all

PDS Biotechnology's competitors and similar companies include 4SC, BioLineRx and ImmunoPhotonics.

	PDS Biotechnology PDS Biotechnology is a biopharmaceutical company focused on the development and commercialization of therapies based on the versamune platform.	4SC 4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.	BioLineRx BioLineRx is a biopharmaceutical company focused on oncology.	ImmunoPhotonics Immunophotonics is a biotechnology company developing a proprietary carbohydrate polymer.
Founding Date	Founding Date 2005	Founding Date 1997	Founding Date 2003	Founding Date 2008
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech oncology pharma	Tags Healthcare clinical research drug development oncology	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations Princeton, US HQ Florham Park, US	Locations Planegg, DE HQ	Locations Modi'in-Maccabim-Re'ut, IL HQ	Locations St. Louis, US HQ
Employees	Employees 317% increase	Employees 13	Employees 2414% decrease	Employees 18
Valuation ($)	Valuation ($) N/A	Valuation ($) 74 m	Valuation ($) 38.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €2.6m (FY, 2025)	Revenue (est.) $1.2m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €45k (FY, 2025)	Cost of goods $230k (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €2.5m (FY, 2025)	Gross profit $950k (FY, 2025)	Gross profit N/A
Net income	Net income ($34.5m) (FY, 2025)	Net income (€3.5m) (FY, 2025)	Net income ($2m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 2m	Total funding raised N/A	Total funding raised $ 100.9m	Total funding raised $ 3.1m